May 17, 2021 03:21 PM IST

India has 26 potential cases of bleeding, clotting after AstraZeneca vaccine

"There is a very miniscule but definitive risk of thromboembolic events" after being vaccinated, the data showed.

As vaccines become scarce, states adopt different strategies to secure supplies

While some municipalities are, or will issue tenders to procure vaccines, others are directly talking to manufacturers. The smaller provinces seem to be depending on distribution by the central government.

COVID-19 crisis | Uttar Pradesh to spend up to $1 billion to buy vaccines, in talks with Pfizer, Sputnik V

The move by Uttar Pradesh, home to more people than Brazil, comes as many Indian states curtail vaccinations due to severe shortages amid a record surge in coronavirus infections, with India recording more than 4,000 deaths for a second straight day as its health system fails to cope.

Brazil suspends use of AstraZeneca COVID-19 vaccine in pregnant women

The 35-year-old woman, who died on May 10, was 23 weeks pregnant, Anvisa said, adding that it had not been informed of any other adverse events involving pregnant women.

Joe Biden’s COVID-19 vaccine shift has risky side effects

What are the blood clots associated with the Johnson & Johnson COVID-19 vaccine? 4 questions answered

A small number of people in the U.S. have developed dangerous blood clots after receiving the Johnson & Johnson vaccine. The clots have mostly been occurring in people’s brains and, paradoxically, are associated with low platelet counts.

AstraZeneca reports COVID vaccine sales of $275 million, expects hit to ease

Vaccine revenue included delivery of about 68 million doses, AstraZeneca said on Friday, adding that sales in Europe, where it faces a legal case, were $224 million, in emerging markets $43 million and $8 million in the rest of the world.

COVID-19 | British regulator cites 41 more blood clot reports following AstraZeneca shots

There has been scrutiny of the AstraZeneca COVID-19 vaccine on the issue of the very rare clots, with a higher incidence in younger people.

How the EU and AstraZeneca ended up in court, and what next

A first hearing in the case began at the Brussels Court of First Instance on Wednesday. The proceedings are public and conducted under an emergency procedure, which means they could be concluded in a matter of weeks, the European Union's executive Commission said.

India expects biggest share of US doses of AstraZeneca vaccine: Report

On Monday, the White House said 10 million doses could be cleared for export "in coming weeks" and the rest by June. It has not revealed potential beneficiaries, but the sources said India could gain the most.

US will share AstraZeneca vaccines with world

The move comes as the White House is increasingly assured about the supply of the three vaccines being administered in the US, particularly following the restart of the single-dose Johnson & Johnson shot over the weekend.

EU launches legal action against vaccine-maker AstraZeneca

The AstraZeneca vaccine has been central to Europe’s immunization campaign, and a linchpin in the global strategy to get vaccines to poorer countries. But the slow pace of deliveries has frustrated the Europeans and has been blamed in part for holding up the EU’s vaccine rollout.

AstraZeneca vaccine benefits increase with age: EMA

The European Medicines Agency (EMA) was presenting its findings after the European Commission asked it to look into concerns that prompted several countries to restrict its use to older people.

COVID-19 update | UNICEF says AstraZeneca supply issues outside India resolved

UNICEF also expects to receive 50 million doses of the shot from the Serum Institute of India in May, compared with almost none this month as the company tries to meet demand in its home country that is battling a huge jump in infections.

COVID-19 update | European Union to get 50 million Pfizer doses early as Denmark scraps AstraZeneca

Denmark becomes first country in EU to drop AstraZeneca vaccine over suspected side effects

Despite recommendations from the World Health Organization and European medicines watchdog to continue using the inoculation, "Denmark's vaccination campaign will go ahead without the AstraZeneca vaccine," Health Authority director Soren Brostrom told a press conference.

Elderly show similar antibody response to first dose of AstraZeneca, Pfizer COVID-19 shots: UK study

The UK study also found that a critical component of the immune system known as T cells showed a more enhanced response in those who got the AstraZeneca/Oxford University vaccine than in those who got the Pfizer/BioNTech one.

US Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases

Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.

Australia backs Pfizer virus vaccine over AstraZeneca for under-50s

The move, after Europe’s drug regulator found a possible link between the Anglo-Swedish vaccine and rare blood clotting issues, is a huge hurdle for Australia's faltering inoculation effort, which relies heavily on the AstraZeneca vaccine.

AstraZeneca has sent Serum Institute a legal notice over delays in COVID-19 vaccine supply: Adar Poonawalla

SII will prioritise supplies to India over the next one or two months, Poonawalla has said.

EU agency says AstraZeneca clot risk 'very rare' as nations battle virus surges

"EMA's safety committee has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects" of the shot, the Amsterdam-based EU drug regulator said in a statement.

India's Serum Institute asks government for $403 million to boost AstraZeneca vaccine output

About 90 percent of the 86 million doses India has administered since mid-January have come from the Serum Institute of India, with the rest accounted for by a domestic vaccine developed by Bharat Biotech, which is also struggling to boost output.

EU agency to share results of probe into AstraZeneca shot

Earlier this week, a senior official from the European Medicines Agency said there was a causal link between the AstraZeneca vaccine and the rare clots that have been seen in dozens of people worldwide, among the tens of millions who have received at least one dose of the shot.

COVID-19 Update | WHO says AstraZeneca benefits outweigh risks; assessing latest data

The WHO is closely studying the latest data alongside European and other regulators, in light of reports of blood clots among people who have been vaccinated.

COVID-19 update | A year after pandemic hit, Haiti awaits vaccines amid apathy

So far, Haiti is slated to receive only 756,000 doses of the AstraZeneca vaccine through a United Nations program aimed at ensuring the neediest countries get COVID-19 shots.